1- [2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of pain or residual symptoms in depression relating to sleep and cognition
Details for Australian Patent Application No. 2008228638 (hide)
International Classifications
Event Publications
15 October 2009 PCT application entered the National Phase
PCT publication WO2008/113359 Priority application(s): WO2008/113359
20 September 2012 Application Accepted
Published as AU-B-2008228638
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2008228637-Liquid formulations of salts of 4-[2-(4-methylphenylsulfanyl)phenyl]pip eridine
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser